A phase II study of intensity modulated radiation therapy (IMRT) with chemotherapy for cervical esophageal cancer (JROSG12-1)
Phase 2
- Conditions
- cervical esophageal cancer
- Registration Number
- JPRN-UMIN000009880
- Lead Sponsor
- Japanese Radiation Oncology Study Group(JROSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Not provided
Exclusion Criteria
i) Simultaneous or metachronous (within 5 years) double cancers; ii) Systemic infections disease; iii) Body temperature of 38C or higher; iv) Women during pregnancy or breast-feeding; v) Psychiatric disease and/or depression; vi) Continuous systemic steroids medication; vii) HBs antigen positive; viii) Uncontrollable diabetes mellitus; ix) Uncontrollable hypertension; x) Myocardial infarction within 6 months or unstable angina pectoris; xi) Serious complications (interstitial pneumonia, pulmonary fibrosis, COPD, heart failure, etc.); xii) cerebrovasucular disease within 6 months; xiii) Histoty of collagen diseases; xiv) History of surgery of esophagus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method